CAVACAVARevenue: is the business selling more than it used to?
$1.2B+22% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $1.2B in 2025, compounding +28% a year since 2022 and the pace is picking up. The trailing twelve months are already running at $1.4B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVANet income: how much of that revenue becomes profit?
$64M−51% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $64M in 2025, against $130M the year before. Earnings per share moved -53% over the last twelve months. Trailing twelve-month profit stands at $66M.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAHow fast is it growing, year by year?
+22.4%revenue growth, FY 2025
Off the axis: 2024 earnings +881.3% - rebounds off a collapsed prior year.
→Revenue grew +22% in 2025 against a five-year average of +24%. Earnings went the other way (-51%) even as sales grew, so margins compressed: costs rose faster than revenue. 2024's +881% earnings rebound off a collapsed base sits off the axis.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVARevenue per share: is your slice growing as fast as the company?
$9.97revenue per share, FY 2025
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-12), not a full fiscal year
→Revenue per share reached $9.97 in 2025, compounding -71% a year against +28% for CAVA as a whole. Dilution absorbed about 99.2 points of that growth. Free cash flow per share stands at $0.22.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAFree cash flow: what is left in real cash after everything?
$26M−51% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow was $26M in 2025. The trailing twelve months stand at $49M.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAHow much of every sales dollar ends up as free cash?
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→2 cents of every sales dollar became free cash in 2025, up 20 points since 2022.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAWhat does staying competitive cost, per dollar of sales?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-12), not a full fiscal year
→The biggest claim on each sales dollar is capital spending, at 13% of revenue (stock compensation 1%). That share has fallen since 2022, so the cost of competing is easing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAMargins: of every $1 of sales, how much survives each cost layer?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-12), not a full fiscal year
→Operating margin widened 15 points to 5% since 2022. After everything, 5 cents of each sales dollar reaches net profit.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAWhat does it earn on the money it uses?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-12), not a full fiscal year
→ROE of 8% sits well above ROCE of 5%. A meaningful share of the shareholder return is manufactured with leverage rather than operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAWhat has the market paid for CAVA over time?
108.5xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 108.5x earnings, the market is paying 28% less than CAVA's own 3-year median of 151.0x. Pessimism is priced in - the question is whether it is deserved.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAWhat cash return does the business throw off per dollar of market value?
0.7%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 0.7% of annual free cash flow, more than its 3-year median of 0.3% - the cash is cheaper than usual.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVACould it handle its debt if things went wrong?
→Debt isn't clearly tagged in CAVA's filings, so treat the balance sheet with extra care rather than assuming zero.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAIs the company's own capital growing?
→The company's own capital grew from $571M in 2023 to $841M (+47%). The business is building book value rather than consuming it.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAHow much goes back, and how much leaks out as stock comp?
→Shareholders received $3M in buybacks in 2023. Stock compensation issued $15M of new shares in the same year, offsetting 100% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAHow fast is your ownership being diluted - or concentrated?
→The share count grew 0.0% in 2025, averaging 1588.0% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVADoes CAVA earn more on its capital than that capital costs?
→CAVA earns 4.6% on the capital it employs, below the 10% most investors treat as the cost of capital. That is the highest in CAVA's filed history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVACAVA has issued or retired shares - did shareholders end up better off?
→CAVA issued +16058% more shares from 2021 to 2025 and revenue per share still fell -99%. On this measure the new shares have not paid for themselves.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12
CAVACAVAAre the people running it buying or selling?
→Insiders bought $1M and sold $286M on the open market, a net sale of $285M. A further 21 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-12